63 related articles for article (PubMed ID: 36263650)
1. Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months Later.
Gasnier M; Choucha W; Montani D; Noël N; Verstuyft C; Radiguer F; Monnet X; Becquemont L; Corruble E; Colle R;
Clin Psychopharmacol Neurosci; 2022 Nov; 20(4):762-767. PubMed ID: 36263650
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine Increased Anxiety-Like Behaviors and Disrupted the Expression of Some Related Genes in the Mouse Brain.
Xu H; Zhang XY; Wang WW; Wang J
Front Pharmacol; 2021; 12():633112. PubMed ID: 33953673
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
4. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
5. Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea.
Bae S; Ghang B; Kim YJ; Lim JS; Yun SC; Kim YG; Lee SO; Kim SH
Viruses; 2021 Feb; 13(2):. PubMed ID: 33672785
[TBL] [Abstract][Full Text] [Related]
6. Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study.
Huang HD; Jneid H; Aziz M; Ravi V; Sharma PS; Larsen T; Chatterjee N; Saour B; Aziz Z; Nayak H; Trohman RG; Krishnan K
Cardiol Ther; 2020 Dec; 9(2):523-534. PubMed ID: 33058086
[TBL] [Abstract][Full Text] [Related]
7. Day-90 survival in critically-ill patients with COVID-19 and hydroxychloroquine: a propensity analysis.
Cour M; Amaz C; Bohé J; Rimmelé T; Ovize M; Argaud L
Ann Transl Med; 2021 Apr; 9(7):524. PubMed ID: 33987222
[TBL] [Abstract][Full Text] [Related]
8. Comparing the impact of Hydroxychloroquine based regimens and standard treatment on COVID-19 patient outcomes: A retrospective cohort study.
Almazrou SH; Almalki ZS; Alanazi AS; Alqahtani AM; Alghamd SM
Saudi Pharm J; 2020 Dec; 28(12):1877-1882. PubMed ID: 33020690
[TBL] [Abstract][Full Text] [Related]
9. Impact of Hydroxychloroquine on Mortality in Hospitalized Patients with COVID-19: Systematic Review and Meta-Analysis.
Hong TS; Gonzalez J; Nahass RG; Brunetti L
Pharmacy (Basel); 2020 Nov; 8(4):. PubMed ID: 33167571
[TBL] [Abstract][Full Text] [Related]
10. Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients.
Ulrich RJ; Troxel AB; Carmody E; Eapen J; Bäcker M; DeHovitz JA; Prasad PJ; Li Y; Delgado C; Jrada M; Robbins GA; Henderson B; Hrycko A; Delpachitra D; Raabe V; Austrian JS; Dubrovskaya Y; Mulligan MJ
Open Forum Infect Dis; 2020 Oct; 7(10):ofaa446. PubMed ID: 33134417
[TBL] [Abstract][Full Text] [Related]
11. [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].
Chen J; Liu D; Liu L; Liu P; Xu Q; Xia L; Ling Y; Huang D; Song S; Zhang D; Qian Z; Li T; Shen Y; Lu H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(2):215-219. PubMed ID: 32391667
[TBL] [Abstract][Full Text] [Related]
12. Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen.
Bernardini A; Ciconte G; Negro G; Rondine R; Mecarocci V; Viva T; Santini F; de Innocentiis C; Giannelli L; Witkowska E; Locati ET; Castelvecchio S; Marrocco-Trischitta MM; Vicedomini G; Menicanti L; Pappone C
Int J Cardiol; 2021 Feb; 324():242-248. PubMed ID: 32956782
[TBL] [Abstract][Full Text] [Related]
13. Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study.
Jung SY; Kim MS; Kim MC; Choi SH; Chung JW; Choi ST
Clin Microbiol Infect; 2021 Apr; 27(4):611-617. PubMed ID: 33316402
[TBL] [Abstract][Full Text] [Related]
14. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.
Taquet M; Geddes JR; Husain M; Luciano S; Harrison PJ
Lancet Psychiatry; 2021 May; 8(5):416-427. PubMed ID: 33836148
[TBL] [Abstract][Full Text] [Related]
15. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine serum concentration in coronavirus disease 2019 (COVID-19) patients: a retrospective study.
Zohra SF; Nassima L
Forensic Sci Res; 2021; 6(3):215-217. PubMed ID: 34868713
[TBL] [Abstract][Full Text] [Related]
17. Use of Hydroxychloroquine in Patients with COVID-19: A Retrospective Observational Study.
Lotfy SM; Abbas A; Shouman W
Turk Thorac J; 2021 Jan; 22(1):62-66. PubMed ID: 33646106
[TBL] [Abstract][Full Text] [Related]
18. Uptrend in distress and psychiatric symptomatology in pregnant women during the coronavirus disease 2019 pandemic.
Berthelot N; Lemieux R; Garon-Bissonnette J; Drouin-Maziade C; Martel É; Maziade M
Acta Obstet Gynecol Scand; 2020 Jul; 99(7):848-855. PubMed ID: 32449178
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 patients managed in psychiatric inpatient settings due to first-episode mental disorders in Wuhan, China: clinical characteristics, treatments, outcomes, and our experiences.
Xie Q; Fan F; Fan XP; Wang XJ; Chen MJ; Zhong BL; Chiu HF
Transl Psychiatry; 2020 Oct; 10(1):337. PubMed ID: 33009366
[TBL] [Abstract][Full Text] [Related]
20. Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises.
Purgato M; Gastaldon C; Papola D; van Ommeren M; Barbui C; Tol WA
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD011849. PubMed ID: 29975811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
